Comgest Growth Europe EUR Acc
Sub-fund of Comgest Growth PLC (Open Ended Investment Company domiciled in Ireland)
Fund is the popular name for UCI (Undertaking for Collective Investment). A UCI is an undertaking that brings together several investors and invests their deposited money in various investment products, such as stocks, bonds, cash, etc., in order to spread the risk.
Before you proceed with investing, you must read and evaluate the KIID and prospectus. The KIID sets out the objectives, investment policy, risks and benefits, and costs and past performance of the fund.
Source NAV www.beama.be
KEY INFORMATION
LEGAL DOCUMENTS
PERFORMANCE
ANALYSIS

Fund Profile

Category: Open Ended Investment Company

The objective of the Fund is to increase the value of the Fund (capital appreciation) over the long term. The Fund intends to achieve this objective through investment in a portfolio of high-quality, long-term growth companies. The Fund will invest at least two-thirds of its assets in securities issued by companies that have their headquarters in, or principally carry out their activities in Europe or which are guaranteed by European governments. While the Fund will primarily invest in shares and other securities related to shares, it may invest in investment grade debt securities, such as European government bonds, where it is deemed in the best interest of the investors. The Fund may invest in other sub-funds of Comgest Growth plc. The Fund is actively managed. This means that the Fund manager applies a detailed fundamental analysis in order to selectively pick companies in a discretionary manner. The Fund is not managed relative to a benchmark index. The base currency of the Fund is EUR. For non-distributing share classes, income earned by the Fund is fully reinvested. Distributing share classes may pay income earned to investors through dividends. Due to the long-term objective of the Fund, the Fund may not be appropriate for investors who plan to invest for less than 5 years. Shares in the Fund trade every day that is a business day in Dublin. You can place an order to buy or sell shares on any business day. The Fund may use fx forwards with the aim of limiting the effect that changes in foreign exchange rates may have on the value of the Fund. Fx swaps may be used for the purpose of rolling maturing fx forward contracts.

Risk Profile
Significant risks that are not adequately reflected in the profile:

Counterparty risk
If a fund counterparty becomes insolvent, it can no longer, or only partially, pay outstanding obligations.
Currency risk
The fund can be adversely affected by exchange rate fluctuations.
Volatility risk
The value of the fund may experience quite large daily upside or downside variations.

You will find all other risks associated with this fund in the prospectus.
Morningstar Rating
More information about the calculation of the Morningstar Ratings
Silver
Silver
Risk and reward profile
1
2
3
4
5
6
7
Lower Risk
Possible Lower
Returns
Higher Risk
Possible higher
Returns
Key Information
Closing Price 23/09/2021 41.27
Morningstar category Europe Large-Cap Growth Equity
Currency EUR
Distribution status Capitalizing
ISIN IE0004766675
Inception Date 15/05/2000
Maturity date Unlimited
Management strategy (vs benchmark) Active
Minimum initial amount 100.00 EUR
Fees And Charges
Entry fee None
Tax on entry None
Custody fees None
Tax on returns
No
Tax on dividend N/A
Exit fee None
Tax on exit 1.32 (max. 4,000.00 EUR per fund)
Ongoing charge 1.56% of which 0.50% is paid to MeDirect
Fund management company
Address Comgest Asset Management Intl Ltd Fifth Floor, Fitzwilton House Wilton Place Dublin Ireland
Manager Name Laurent Dobler
Manager Start Date 01/01/2006
Website www.comgest.com
Total Net Assets (mil) 4,774.38 EUR (31/08/2021)
UCITS Yes
Administrator RBC Investor Services Ireland Ltd

Legal Documents

It is possible that this fund applies swing pricing. Please consult the prospectus for more information.
Should you have any complaints, you may contact Compliance Officer MeDirect, Keizerinlaan 66, 1000 Brussel or via [email protected] or Ombudsfin, Ombudsman for financial disputes, North Gate II, Koning Albert II – laan 8 bus 2, 1000 Brussel or via [email protected]

Performance

Historical returns returns and the evolution of the NAV are no guarantee for future performances. Investing in Financial markets and securities involves risk. Past performance is not a guarantee of future results. Investment losses may occur and investors could lose some or all of their investment in the Fund.
Sales charges (like entry- and exit fees ) and taxes are not included in the calculation of past performance. Management fees, administrative fees and other costs taken out of the fund assets have been taken in to account, as they are already included in the NAV.
Annualised performance in EUR
PeriodAnnualised returnDate
1 year39.14%23/09/2021
3 years17.55%23/09/2021
5 years14.71%23/09/2021
10 years15.02%23/09/2021
Since launch6.86%23/09/2021
Cumulative performance in EUR
Performance
YTD 01/01/202127.10
1 month1.73
3 months11.03
6 months24.46
Quarterly Returns
Q 1Q 2Q 3Q 4
20214.56%10.40%--
2020-11.90%13.20%2.09%8.74%
201915.53%5.57%3.07%6.54%
2018-3.82%10.78%4.11%-14.35%
20177.78%2.50%0.75%1.36%

Analysis

Asset Allocation
% Long% Short% Net Assets
Stock98.97%0.00%98.97%
Bond0.00%0.00%0.00%
Cash1.03%0.00%1.03%
Other0.00%0.00%0.00%
Return/Risk Analysis
Risk Measurement1 Year3 Years5 Years
Standard Deviation
13.6014.3212.44
Sharpe Ratio
2.431.151.19
Sortino Ratio
6.221.922.04
Positive Months10.0026.0040.00
Negative Months2.0010.0020.00
Worst Month-4.66-7.94-7.94
World Regions
Region%
Eurozone59.30
Europe - ex Euro27.62
United States6.21
United Kingdom5.83
Stock Sector Weighting
Sector% of Equity
Healthcare28.45
Technology21.23
Industrials13.12
Consumer Cyclical
12.57
Consumer Defensive
11.87
Basic Materials6.40
Communication Services3.04
Top 10 Holdings
HoldingSectorCountry% of Assets
ASML Holding NV TechnologyNetherlands7.76
Essilorluxottica HealthcareFrance4.67
Novo Nordisk A/S B HealthcareDenmark4.62
LVMH Moet Hennessy Louis Vuitton SE Consumer CyclicalFrance4.39
Roche Holding AG HealthcareSwitzerland3.99
Linde PLC Basic MaterialsUnited Kingdom3.85
Heineken NV Consumer DefensiveNetherlands3.58
Accenture PLC Class A TechnologyUnited States3.42
Industria De Diseno Textil SA Consumer CyclicalSpain3.34
Dassault Systemes SE TechnologyFrance3.34
It is possible that some UCI presented in the portfolio are not offered in Belgium, please verify with our client service
Classification of Morningstar Category
Ranking1 Year2 Years3 Years5 Years
Top 25%
Category above the average
Category below the average
Bottom 25%
Morningstar Style Box
Equity Style
Large
Size
Mid
Small
Value
Blend
Growth
Style
All key information and documents must be reviewed before being able to Invest.